Skip to Content
Still using that old version of Internet Explorer? This site will work much better in a newer version of IE or Firefox.
Download Internet Explorer 8 or Firefox 3 now!

malaria

Improving malaria case-management practices in the public sector

Principal Investigator(s): 
Dejan Zurovac

Since 2004 standard malaria treatment guidelines across Africa have universally changed to support the management of clinical malaria in formal, public health services with ACTs, representing one of the most significant policy changes in malaria. However, we have shown through facility-based studies in Kenya, Uganda, Zambia and Somalia that malaria case-management in the public sector remains characterized by a poor drug supply, inappropriate prescription practices, inadequate counselling of patients and a disregard of results of parasitological diagnosis aimed at reducing over-treatment.

Malaria control in school children

Principal Investigator(s): 
Simon Brooker

The risks and severity of clinical outcomes following exposure to P. falciparum increase among older children as transmission intensity declines. Malaria control in Africa has focused on pre-school children and pregnant women over the last decade, but as transmission intensity declines school aged children will become an important clinical risk group. As a result of a historical pre-school prevention focus, we have shown that children aged 5-19 years have the lowest ITN use in any community and thus pose a threat to universal coverage targets and abilities to reduce local transmission. Our group have undertaken randomized-controlled and plausibility trials of malaria prevention among school children, notably IPTsc and the delivery of ITN to school children in hard-to-reach areas.

Human population movement and vulnerability to importation of malaria

A public health consequence of reductions in local malaria transmission is the risk posed by imported malaria to areas aiming for elimination. A series of meta-analysis GIS model frameworks will be developed using varied data sources on malaria risks and human movement (including national census data, mobile phone data and nested detailed case studies) to quantify the extent, reach and possible threats to the changing malaria landscape in Kenya and other parts of East and Horn of Africa.

Epidemiology of malaria transmission in neglected, semi-arid areas of Africa

Principal Investigator(s): 
Abdisalan Mohamed Noor

Unlike stable transmission settings in Africa the drivers of focal, heterogeneous infection and disease risks among the arid areas of Africa remain poorly defined. The populations in North West and North Eastern Kenya are poor, semi-nomadic groups with little acquired functional immunity to P. falciparum, marginalized by the 2001-09 national malaria strategy as they were assumed to be at no risk. Risks however, appear to be very focal concentrated in areas of seasonal water which also determines where people live. A more detailed empirical investigation of malaria risk, including susceptibility to P.

The cost-efficiency of sampling malaria risk and markers of infection prevalence

Defining the risks of P. falciparum infection can be measured using a variety of techniques in different populations but their cost and sensitivity depend on the overall levels of risk and the sampling strategies adopted. Central to continued mapping work is the need to define optimal spatial sampling procedures, their costs and the skill with which one needs to define infection risks. Statistical modelling of optimal spatial sampling methods will be explored against empirical sampling frames and costs of assembling data at clinics, schools and communities.

Modelling the changing infection risks and malaria burdens in Kenya

Principal Investigator(s): 
Bob Snow
Principal Investigator(s): 
Abdisalan Mohamed Noor

Kenya provides a unique set of opportunities to apply the principles of high-spatial resolution geo-statistical modelling with its rich prospectively collected national data on parasite prevalence, intervention coverage and associated covariates that relate to access to interventions and malaria risk. This work has already formed the basis of recent strategic planning for malaria control in Kenya and will be used to quantify the population-attributable infection risk reduction associated with scaled, spatially quantified intervention coverage to predict changing morbidity and mortality impact using appropriate epidemiological and burden of disease models for Kenya through to 2016.

Malaria Atlas Project – Africa

Principal Investigator(s): 
Bob Snow

We have produced the first ever empirical global map of P. falciparum risk using rigorous geo-statistical models of infection prevalence, remotely sensed proxies of climate and human settlement. Over 98% of the Plasmodium falciparum endemic world where transmission intensity exceeds 40% prevalence is located in Africa. Africa continues to bear the greatest global malaria disease burden. The MPHEG will continue to assemble temporally and spatially configured empirical information on malaria infection prevalence, intervention coverage and funding.

Haemodynamics in children with acute non-traumatic coma

Cerebral malaria, meningitis and encephalitis are the most common causes of acute encephalopathies in children in sub-Saharan Africa. All are associated with seizures and may be complicated by shock and intracranial hypertension. These features are associated with prolonged coma, increased mortality and both short and long-term cognitive and neurological deficits. Children with multiple risk factors have even poorer outcomes.


Seizures may be completely unapparent clinically. Clinical signs of intracranial hypertension are a late feature and intracranial pressure monitoring is an invasive procedure unavailable in most health units in sub-Saharan Africa.

Patricia Njuguna

Email: 
pnjugunaatkilifi [dot] kemri-wellcome [dot] org
Group: 
Clinical Group

Patricia Wambui Njuguna is Paediatrician based in Kilifi, Kenya. She graduated with a Masters in Medicine (Paediatrics and Child Health) (University of Nairobi) in 2006.

Antimalarial potential of Methotrexate and aminopterin

Full Title: 
Development of New Drugs for the Treatment of Malaria: The antimalarial potential of Methotrexate and aminopterin
Principal Investigator(s): 
Alexis Nzila

European Union grant from March 2007 to March 2010 on the "Development of New Drugs for the Treatment of Malaria: The antimalarial potential of Methotrexate and aminopterin"